Available as consumer-facing supplements and as licensable functional food ingredients for the food and beverage industry, Pivit's patented weight management formulations are engineered to stimulate secretion of GLP-1 alone, GLP-1 and GIP together, or the full triple-hormone axis of GLP-1, GIP, and Peptide YY (PYY)
Hopefully, our findings altogether expand our current understanding of DAT regulation and its implication in ADHD and add values to future therapeutic development
Medicare does NOT cover Zepbound for weight loss because federal law prohibits Medicare from covering drugs used primarily for weight management
Sodium abnormalities typically only occur when significant vomiting, diarrhea, dehydration, or excessive water intake accompany GLP-1 RA use
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the treatment of obesity and type 2 diabetes mellitus (T2DM) by mimicking endogenous GLP-1 activity, increasing glucose-dependent insulin secretion and suppressing glucagon release
1,2,3 As pharmacies or outsourcing facilities operating under 503Aor 503B of the Federal Food, Drug, and Cosmetic (FD&C) Act, we are restricted to working with only certain materials as bulk active pharmaceutical ingredients